Thu Sep 26 12:53:08 UTC 2024: ## OPKO Health (OPK) Stock Receives “Buy” Rating from HC Wainwright
**[City, State] -** OPKO Health (NASDAQ:OPK), a healthcare company involved in diagnostics and pharmaceuticals, has received a “buy” rating from HC Wainwright, with a price target of $3.00, representing a potential upside of 102.70% from its current price. This optimistic assessment follows OPKO Health’s recent earnings report, where the company beat analysts’ estimates on earnings per share, despite revenue falling short of expectations.
Other analysts have also weighed in on OPKO Health, with Barrington Research reaffirming an “outperform” rating and a $2.25 target price, while Piper Sandler reiterated an “overweight” rating and a $3.00 target price. However, StockNews.com has downgraded OPKO Health to a “sell” rating.
Despite the mixed signals, OPKO Health has seen notable activity from institutional investors. Rubric Capital Management LP significantly increased its holdings in the company, while Y.D. More Investments Ltd, Squarepoint Ops LLC, Lazard Asset Management LLC, and BNP Paribas Financial Markets have also acquired new positions in OPKO Health.
OPKO Health’s performance in the coming months will be closely watched as investors assess the company’s potential for growth in the diagnostics and pharmaceuticals sectors.
**[This is a sample news article, please include relevant city/state information where appropriate and replace bracketed information with specific details.]**
First Piper 